Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v2-FR
Language French French
Date Updated 2020-06-22 2020-06-22
Drug Identification Number 02416522 02416522
Brand name OLANZAPINE FOR INJECTION OLANZAPINE FOR INJECTION
Common or Proper name OLANZAPINE FOR INJECTION OLANZAPINE FOR INJECTION
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients OLANZAPINE OLANZAPINE
Strength(s) 10MG 10MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAMUSCULAR INTRAMUSCULAR INTRAMUSCULAR
Packaging size I PSIJ I PSIJ
ATC code N05AH N05AH
ATC description ANTIPSYCHOTICS ANTIPSYCHOTICS
Reason for discontinuation Manufacturing issues Manufacturing issues
Anticipated discontinuation date
Actual discontinuation date 2020-06-19 2020-06-19
Remaining supply date 2020-06-19 2020-06-19
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Information on remaining supply
Company comments
Health Canada comments